Veracyte (VCYT) Cash from Financing Activities (2012 - 2026)
Veracyte (VCYT) posted Cash from Financing Activities of -$6.6 million for Q1 2026, down 4348.99% sequentially from -$149000.0 in Q4 2025, and down 2.24% YoY from -$6.8 million in Q1 2025.
Veracyte (VCYT) Cash from Financing Activities (2012 - 2026) Analysis & Trends
Veracyte (VCYT) has 15 years of Cash from Financing Activities data on file, last reported at -$6.6 million in Q1 2026.
- Quarterly Cash from Financing Activities fell 2.24% year-over-year to -$6.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.4 million (down 509.92% YoY) and the FY2025 annual result came in at -$4.2 million, down 186.09% from the prior year.
- Cash from Financing Activities retreated to -$6.6 million in Q1 2026 per VCYT's latest filing, from -$149000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $10.3 million in Q3 2024, with the low at -$6.6 million in Q1 2026.
- Average Cash from Financing Activities over 5 years is $22588.2, with a median of $93000.0 recorded in 2022.
- Year-over-year, Cash from Financing Activities soared 9253.64% in 2024 and plunged 5045.45% in 2025.
- Veracyte's Cash from Financing Activities stood at $93000.0 in 2022, then soared by 593.55% to $645000.0 in 2023, then sank by 799.22% to -$4.5 million in 2024, then soared by 96.7% to -$149000.0 in 2025, then slumped by 4348.99% to -$6.6 million in 2026.
- Business Quant data shows VCYT's Cash from Financing Activities at -$6.6 million in Q1 2026, -$149000.0 in Q4 2025, and $3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 3.76 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -144.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Veracyte | 4.76 Bn | 4.50 Bn | 101.16 Mn | -6.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.63 Mn |
| Mar 31, 2026 | -6.63 Mn |
| Dec 31, 2025 | -149,000.00 |
| Dec 31, 2025 | -149,000.00 |
| Sep 30, 2025 | 2.98 Mn |
| Sep 30, 2025 | 2.98 Mn |
| Jun 30, 2025 | -566,000.00 |
| Jun 30, 2025 | -566,000.00 |
| Mar 31, 2025 | -6.48 Mn |
| Mar 31, 2025 | -6.48 Mn |
| Dec 31, 2024 | -4.51 Mn |
| Dec 31, 2024 | -4.51 Mn |
| Sep 30, 2024 | 10.29 Mn |
| Sep 30, 2024 | 10.29 Mn |
| Jun 30, 2024 | -11,000.00 |
| Jun 30, 2024 | -11,000.00 |
| Mar 31, 2024 | -864,000.00 |
| Mar 31, 2024 | -864,000.00 |
| Dec 31, 2023 | 645,000.00 |
| Dec 31, 2023 | 645,000.00 |